You are about to leave the Cytrellis site and be transferred to an independent medical portal.

Real Results

Physicians and patients report remarkably positive clinical results

Through our extensive pre-clinical and clinical research, we have established in-depth knowledge of our device and developed an ideal protocol.* As a result of our pivotal clinical study, ellacor® is FDA cleared for the treatment of moderate to severe wrinkles in the mid to lower face for adults ages 22+ with Fitzpatrick Skin Types I-IV.**

Before & After Results

See more results

1. Pivotal Study to Evaluate the Effectiveness of a Micro-Coring® Device Treating Moderate to Severe Facial Wrinkles. ClinicalTrials.gov NCT 03573271; submitted for publication. 51 subjects completed the pivotal study; subjects were treated 2-3 times with 7%-8% skin removal and up to 5mm needle coring depth. Each patient heals differently; mild to moderate side effects may still be present up to 30 days post-treatment per physician assessment. All clinical data, including patient healing, treatment pain on the 0-10 Wong-Baker
Scale, Global Aesthetic Improvement Scale scores, and Subject Satisfaction is on file with Cytrellis.

2. Champlain, A. et al. 2019. What is the Largest Size Full-Thickness Skin Injury That Can Heal Without a Scar? Lasers in Surgery and Medicine, 50(S30), S30-31. https://doi.org/10.1002/lsm.23059

*The ellacor® System with Micro-Coring® Technology is indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

**Data on file.